These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1445501)

  • 1. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Behmand RA; Harik SI
    J Neurochem; 1992 Feb; 58(2):776-9. PubMed ID: 1445501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin.
    Parain K; Hapdey C; Rousselet E; Marchand V; Dumery B; Hirsch EC
    Brain Res; 2003 Sep; 984(1-2):224-32. PubMed ID: 12932857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
    Shahi GS; Das NP; Moochhala SM
    Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
    Quik M; Parameswaran N; McCallum SE; Bordia T; Bao S; McCormack A; Kim A; Tyndale RF; Langston JW; Di Monte DA
    J Neurochem; 2006 Sep; 98(6):1866-75. PubMed ID: 16882311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
    Sershen H; Hashim A; Wiener HL; Lajtha A
    Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
    Carr LA; Rowell PP
    Neuropharmacology; 1990 Mar; 29(3):311-4. PubMed ID: 2325834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
    Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP
    Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Rojas P; Klaassen CD
    Neurosci Lett; 1999 Oct; 273(2):113-6. PubMed ID: 10505629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Perry TL; Hansen S; Jones K
    Neurosci Lett; 1987 Feb; 74(2):217-20. PubMed ID: 3494963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice.
    Fung YK; Fiske LA; Lau YS
    Gen Pharmacol; 1991; 22(4):669-72. PubMed ID: 1936899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
    Gilad GM; Gilad VH; Finberg JP; Rabey JM
    Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
    Gao ZG; Cui WY; Zhang HT; Liu CG
    Pharmacol Res; 1998 Aug; 38(2):101-6. PubMed ID: 9721596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lu E; Sarkar S; Raymick J; Paule MG; Gu Q
    Brain Res; 2018 Jan; 1678():432-439. PubMed ID: 29158176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
    McGrew DM; Irwin I; Langston JW
    Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.